Your browser doesn't support javascript.
loading
Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients.
Ismail, Mohamed A; Vezzalini, Marzia; Morsi, Hisham; Abujaber, Ahmad; Al Sayab, Ali; Siveen, Kodappully; Yassin, Mohamed A; Monne, Maria; Samara, Muthanna; Cook, Richard; Sorio, Claudio; Modjtahedi, Helmout; Al-Dewik, Nader I.
Afiliación
  • Ismail MA; School of Life Science, Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University London, London, United Kingdom. mhmd_arby@yahoo.com.
  • Vezzalini M; Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), Doha, Qatar. mhmd_arby@yahoo.com.
  • Morsi H; Department of Medicine, University of Verona, Verona, Italy.
  • Abujaber A; Quality of Life Unit, National Center for Cancer Care and Research, (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Al Sayab A; Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Siveen K; Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Yassin MA; Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Monne M; Department of Medical Oncology, National Centre for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar.
  • Samara M; Centro di Diagnostica Biomolecolare e Citogenetica Emato-Oncologica, "San Francesco" Hospital, Nuoro, Italy.
  • Cook R; Department of Psychology, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, United Kingdom.
  • Sorio C; School of Life Science, Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University London, London, United Kingdom.
  • Modjtahedi H; Department of Medicine, University of Verona, Verona, Italy.
  • Al-Dewik NI; School of Life Science, Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University London, London, United Kingdom.
Sci Rep ; 11(1): 8833, 2021 04 23.
Article en En | MEDLINE | ID: mdl-33893334
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Proteínas Tirosina Fosfatasas Clase 5 Similares a Receptores / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Proteínas Tirosina Fosfatasas Clase 5 Similares a Receptores / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido